Senior Director - Therapy Development Mitral & Tricuspid Therapies

We anticipate the application window for this opening will close on - 11 Nov 2026

Careers that change lives start here. Medtronic is a global leader in healthcare technology with a Mission to alleviate pain, restore health, and extend life. Our 95,000 employees work across more than 150 countries to put patients first — developing innovative medical technologies that improve the lives of 72+ million patients each year. Your unique talents will help shape the future of healthcare while building a career grounded in purpose, growth, and impact.

A Day in the Life

The Structural Heart business is advancing innovative mitral and tricuspid therapies designed to address complex valvular heart disease. The Mitral & Tricuspid Therapy Development organization plays a critical role in supporting clinical-stage programs, generating physician and procedural insights, advancing evidence development, and preparing the organization for future commercialization. The team partners closely with Research & Development, Clinical, Regulatory, Medical Affairs, Marketing, Commercial, and Medical Education functions to support therapy adoption, physician training, and launch readiness across a growing portfolio.

This role leads the U.S. Therapy Development organization and provides strategic leadership for global imaging and technical-support capabilities supporting mitral and tricuspid therapies. The position is responsible for building the capabilities, talent, operating models, and organizational readiness required to transition from clinical-stage support to a scalable commercial field organization.

This position may be located anywhere within the United States and is designated as Remote. Travel up to 50% is required to support physician engagement, clinical sites, team leadership, and cross-functional business activities.

The Senior Director, Therapy Development, Mitral & Tricuspid Therapies provides strategic and operational leadership for a field-based organization supporting clinical-stage mitral and tricuspid programs while preparing the business for future commercialization. This leader is accountable for clinical execution, physician engagement, field capability development, organizational readiness, and commercialization planning across a complex portfolio of structural heart therapies.

Primary Responsibilities

Lead the U.S. Therapy Development organization supporting clinical trial execution, physician engagement, procedural success, and customer support across mitral and tricuspid programs.

Provide strategic leadership for global imaging and technical-support teams responsible for patient evaluation, procedural planning, physician education, and therapy development.

Represent Therapy Development on Mitral and Tricuspid New Product Development core teams, influencing field capability requirements, physician adoption strategies, and commercialization readiness plans.

Develop and execute organizational transformation strategies that evolve Therapy Development from a clinical-stage support model into a scalable commercial field organization.

Partner with Clinical, Research & Development, Regulatory, Quality, Medical Affairs, Marketing, Commercial, and Medical Education leaders to align therapy, evidence-generation, and launch-readiness objectives.

Direct physician engagement strategies and translate clinical, imaging, and procedural insights into product-development priorities, training programs, and customer-support models.

Drive launch-readiness planning, including field organization design, talent strategies, training frameworks, resource planning, and customer adoption initiatives.